Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanozyme Aptasensor Array for Predictive Sensing of Virulent and Antibiotic-Resistant Staphylococcus Aureus strains.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Structural Mapping of Surveillance Data Reveals Conservation of NNI Binding Site in RSV L Protein.

Pathogens (Basel, Switzerland)·2026
Same author

Targeting TRP channels: recent advances in structure, ligand binding, and molecular mechanisms.

Frontiers in molecular neuroscience·2024
Same author

Engineered Polymer-siRNA Polyplexes Provide Effective Treatment of Lung Inflammation.

ACS nano·2023
Same author

Inorganic nanoparticles as scaffolds for bioorthogonal catalysts.

Advanced drug delivery reviews·2023
Same author

Antibacterial Nanomaterials: Mechanisms, Impacts on Antimicrobial Resistance and Design Principles.

Angewandte Chemie (International ed. in English)·2023
Same journal

Lipid-based nanocarriers as transformative treatment in tuberculosis: a systematic review of therapeutic efficacy.

Nanomedicine (London, England)·2026
Same journal

UCMSC-Exo for chemotherapy-induced myelosuppression in acute myeloid leukemia: a phase I clinical trial protocol.

Nanomedicine (London, England)·2026
Same journal

Aptamer-functionalized nanoparticles for cancer targeting: conjugation strategies, current applications and future perspectives.

Nanomedicine (London, England)·2026
Same journal

Targeted therapy of highly aggressive thyroid papillary carcinoma by AS1411-guided nanomaterials.

Nanomedicine (London, England)·2026
Same journal

Impacts of curcumin nanoemulgel on cell viability and apoptotic pathways: a comprehensive study of ROS generation across different skin cancer cell lines.

Nanomedicine (London, England)·2026
Same journal

Advancements in single-chain antibody functionalized nanoparticles for the treatment of advanced solid tumors.

Nanomedicine (London, England)·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
07:13

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays

Published on: June 28, 2024

2.2K

Array-based sensing using nanoparticles: an alternative approach for cancer diagnostics.

Ngoc D B Le1, Mahdieh Yazdani, Vincent M Rotello

  • 1Department of Chemistry, University of Massachusetts Amherst, 710 North Pleasant Street, Amherst, MA 01003, USA.

Nanomedicine (London, England)
|September 26, 2014
PubMed
Summary
This summary is machine-generated.

Array-based sensing with nanoparticles (NPs) offers a novel approach to cancer diagnostics. This method generates unique fingerprints for analytes, paving the way for personalized cancer detection and treatment.

Keywords:
array-based sensingchemical nose sensinginvasivenoninvasivepersonalized diagnosticsselective sensing

More Related Videos

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

7.6K
Fabricating a UV-Vis and Raman Spectroscopy Immunoassay Platform
09:02

Fabricating a UV-Vis and Raman Spectroscopy Immunoassay Platform

Published on: November 10, 2016

9.1K

Related Experiment Videos

Last Updated: Apr 23, 2026

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
07:13

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays

Published on: June 28, 2024

2.2K
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

7.6K
Fabricating a UV-Vis and Raman Spectroscopy Immunoassay Platform
09:02

Fabricating a UV-Vis and Raman Spectroscopy Immunoassay Platform

Published on: November 10, 2016

9.1K

Area of Science:

  • Nanotechnology
  • Biomedical Engineering
  • Analytical Chemistry

Background:

  • Traditional cancer diagnosis often relies on specific biomarker detection.
  • Nanoparticles (NPs) possess unique physical and chemical properties suitable for biosensing applications.
  • Array-based sensing offers a pattern-recognition approach for analyte identification.

Purpose of the Study:

  • To review the principles of array-based sensing using nanoparticles for cancer diagnostics.
  • To highlight the potential of NP-based sensors for personalized cancer detection.
  • To discuss examples of invasive and noninvasive sample applications.

Main Methods:

  • Utilizing the inherent recognition and transduction capabilities of nanoparticles.
  • Employing array-based sensor systems to generate distinct analyte fingerprints.
  • Exploring both specific biomarker recognition and chemical nose sensing strategies.

Main Results:

  • Array-based NP sensors can generate unique patterns for different analytes.
  • This approach allows for a holistic analysis beyond single biomarker detection.
  • Demonstrated applicability in both invasive and noninvasive cancer diagnostics.

Conclusions:

  • Array-based sensing with NPs presents a versatile platform for cancer diagnostics.
  • This technology supports the development of personalized diagnostic methodologies.
  • It represents a significant step towards evolving healthcare for tailored cancer treatments.